Marshall. Thanks,
move Slide XX. Let's to
our to enhance release order would presentation today seen of for transparency we our press that from You have our and and in financial have to cash disclosures investors the made to nature changes flows. reflect better
First, as it on announced portfolio receipts adjusted X, receipts. cash previously we with replaced January
metrics performance recorded economics now to amount interests. as adjusted The change net key sums as individual While into the facilitate increased cash be noncontrolling these will transparency royalties, same will the legacy of of this receipts.
This receipts may clarity more over underlying is new our versus into down provide X receipts royalty and portfolio Additionally, to be contractual other in be receipts. subcategories, and on royalty milestone will which payments, time. contractual intended other greater namely trends the portfolio variable broken disclosure
better we our with outflows business to measures inflows new of cash measure help reflect metric, investors flow, a model new Second, non-GAAP and the on the our along liquidity believe cash a these introducing cash deployment. are simplicity capital will business. portfolio We and of flows, performance cash focus our
to XXXX, changes aligned should our SEC. and that and greater XX% to the into business. for to growth other over XX% guidance been we of All we XXXX. of our which believe that expect long-term totality, It portfolio insight unchanged have In cash applied between and to statements, discussed In these are should XXXX you note receipts receipts business receipts. with portfolio these how XXXX with is annual made XX% from Finally, presentation. changes now this more outlook the our new manage rate or we adjusted words, by noted provide be compounded we more
detail granular non-GAAP more provides liquidity XX our metrics. and Slide performance on measures
noted, portfolio. to calculation adjusted measure greater net non-GAAP the adjusted But provide key portfolio less receipts within is unchanged cash I EBITDA calculated disclosures EBITDA non-GAAP as the Portfolio into paid. measure. as key the underlying cash trends and transparency flow, Adjusted is liquidity just new economics previous of is a interest liquidity another our identical receipts. As the
activity by flow are our in all between generated capital cash and primary cash the included flow investment portfolio replaces now It of adjusted substantially to single exclusion development is deployment. outflows a in and payments deployment milestones, cash The cash line. flow substantially difference and measures cash business. Capital which all stage the related adjusted upfront measure
attractive periods. aggregate release thinks previously may value, detailed amount, In paid earnings in also future on payment in receipts arrive to to the deployment of announced our at to to -- to X. Management about in inflows. future portfolio our subtract breakdown and cash We majority milestones announced look provide Page be which of flow a that include vast an the We capital capital expenses growth. we the at cash opposed new transactions portfolio cash pursue royalties our as deployed strategy. included ability at to transaction and of drive We creation which reflects value cash
generate of value. critical our understanding virtuous long-term to business cycle The how is we
Following longer receipts these updates, we will report flow. or adjusted cash cash no adjusted
We have framework posted our XXXX. under to this to financials dating the new historical website back
providing the by additional also website, of including terms, information and are for products significant product modeling. consensus to royalty estimates assist on NCI We section key key Investors our your in
to full our move Let's for strength year, with by on our encouraging. of Royalty the trends financials, remain underlying now The performance year Slide portfolio. full the receipts the on top-line grew quite reflecting XX. diversified starting X%
Additionally, impact of Biohaven related other the show and the milestones on performance. on contractual payments disclosures the receipts reported new
X% XXXX, in million portfolio by the we XXXX. $XXX received. XX% to contractual receipts payments, received grew Biohaven-related being payments, modest other we and XXXX, received in a benefit in relatively $XXX growth impact Biohaven-related XXXX, while with Overall, million year full reminder, milestones net a in to in contributing As
the quarter in the of Slide XX% and year acquisition Spinraza receipts contributions. cystic performance the of and due for XX year more receipts, as fibrosis shows detail, our how portfolio strong as of with full the individual X% well performances including and Beginning Tremfya in was royalty mainly royalty royalties. Trelegy fourth growth the the quarter the to in franchise,
move Trodelvy, the positive Imbruvica Evrysdi, and and factors well also year-over-year and Promacta related weakness payments, noted. impacted expirations of in other the as contributions key just contractual milestones I as Tysabri receipts, category. products were most from were we partially other in by We Cabometyx. our Biohaven including as saw by offset royalty When growth comparisons by to These royalties,
by grew year. full receipts for portfolio together, the Taken X%
be the Slide business reinvested. XX full and in our flow receipts fourth to $XXX substantial shows to billion amounted generates quarter $X.XX efficient for model how cash the million Portfolio year.
year. the move down professional we the receipts column, As X.X% X% the full in for portfolio the and of quarter costs operating and created
the portfolio business further into Moving what adjusted to interest then column, be that when look the value-enhancing royalties, call less now EBITDA down net flow. the have generated to cash that we we we redeployed say cash or consistently stated we paid by
the on equivalent able $X.X of amounted the full billion highlight cash of billion to repurchase in quarter to were billion full around of high the levels and this This comfortably quarter XX% strong approximately margins the $XXX year, to of $XXX based million generation $X.XX we capital $X conversion These and million model. cash profile, as, in efficiency year, as of in well our to deployment fourth our stock. again business XX%, once and the support for Furthermore, respectively.
billion future $X.X debt royalty year available we of million. XX a for the and In capital End quarter, to we fourth our a combination of balance significant deployment, we cash for financial of through total, maintain $XXX to Slide sheet shows markets. was have access cash the capacity acquisitions. on had and while continue that equivalents substantial XXXX
On draw $X.X arose. bonds, our repaid quarter. revolver, debt if top significant opportunity have in to right we financial capacity, we leverage million billion the could you Xx Furthermore, billion previously additional of have $XXX the we to capacity which from EBITDA said of up should total we've take we the maintained the fourth note, which on $X.X investment-grade
our with create feel execute good together to cash Taken to strong generation, value. and we continue our about shareholder transactions ability
financial guidance. our full Slide XX provides XXXX year
$X.X range billion. We expect of to billion be to in the portfolio $X.X receipts
you assumptions. our Let me through walk
First, our receipts. continued offset of expect potential more as diversified well deliver royalty overall growth we and guidance, and in headwind as continued We in of will Tysabri our anticipate to Promacta the it's the top-line strength attractive portfolio generics. launch than Imbruvica
payment basis, a million in received a a last XXXX we of we on $XXX base as face related high of of Second, the reported result year. comparison Biohaven
received modeling quarter your million $XXX Zavzpret For I first was remind element, the that milestone XXXX. of you consideration, the largest the in
As substantially other consequence, XXXX. expected be and milestones a receipts contractual to are in lower
assumes guidance negligible a impact. our Lastly, FX
acquisitions. and consistent account future this on as Importantly is not benefit and with any of guidance royalty standard of the take our based today does our practice, into portfolio
Turning operating to expenses.
to to with does We around quarterly on for costs in $X paid to be full our payable expect payments operating amounts the Interest minimis XXXX portfolio established de This million to be full $XXX X% approximately for in which million amounted expected and into balance, XXXX. in take account professional year QX and to received follow quarter. receipts fourth any X% and million pattern interest cash QX. not $XX for and year the is XXXX
other provides evolution milestones XX on detail contractual versus XXXX. more receipts royalty expected of Slide the and receipts in
royalty The to underlying which contractual to portfolio, deliver expect of XXXX. expected receipts, XXXX. $XXX while growth we our in in and are here from key message decline to expect of receipts around continued royalty to other in X% around million XXXX For attractive X%, growth the $XX milestones is million approximately we
call hand Pablo. I'd back like With to to the that,
